Cure Multitrade Private Limited
About Cure Multitrade Private Limited
Data last updated:
Cure Multitrade Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the jewelry and gemstone retail and distribution segment of the consumer goods sector. It was incorporated on 06 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U11100MH2020PTC340370.
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors Pritam Prafulchandra Karde and Sudhir Harishchanadra Wadkar.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.47 Lakh, a decline of 34% compared to the previous year. For the same year it recorded a net profit of ₹8.26 Lakh (net margin 57.1%) and EBITDA of ₹10.94 Lakh (EBITDA margin 75.6%). Revenue has grown at a compounded annual rate (CAGR) of 57% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat – 302 Shiv Sai Chsl Ltd Shiv Vallabh Road Near Saurashtra Marriage Hall Nr Patel, Borivali E, Mumbai, Maharashtra, India – 400066
- IndustryConsumer Goods, Jewelry & Gemstone Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
CIN History of Cure Multitrade Private Limited
Cure Multitrade has one previous CIN (Corporate Identification Number): U51909MH2020PTC340370. The current CIN is U11100MH2020PTC340370, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U11100MH2020PTC340370 | Current |
| U51909MH2020PTC340370 | Previous |
Board of Directors of Cure Multitrade Private Limited
Cure Multitrade has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudhir Harishchanadra Wadkar Also directs: Omnitech Oilfield Services Private Limited, Optimum Oil & Gas Private Limited, Omkar Natural Resources Private Limited and 1 more | Additional Director | 17 Jun 2025 | 1 Years 3 Months | Current |
| Pritam Prafulchandra Karde | Director | 15 Jun 2020 | 6 Years 3 Months | Current |
Financials of Cure Multitrade Private Limited FY 2025 filings available
Cure Multitrade Private Limited reported revenue of ₹14.47 Lakh (down 34% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Cure Multitrade Private Limited
Revenue fell 34% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 57%. EBITDA fell 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Cure Multitrade Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10.94 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8.26 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Cure Multitrade Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 75.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 57.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Cure Multitrade are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Cure Multitrade Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Cure Multitrade Private Limited
Cure Multitrade Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Cure Multitrade Private Limited
Cure Multitrade Private Limited has a workforce of 0 employees as of Mar 28, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Cure Multitrade Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Cure Multitrade Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cure Multitrade Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cure Multitrade Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cure Multitrade Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Cure Multitrade Private Limited
Frequently Asked Questions about Cure Multitrade Private Limited
Cure Multitrade is an active private limited company based in Mumbai, Maharashtra, India. The company works in jewelry and gemstone retail and distribution, within the consumer goods industry. It was incorporated on 06 June 2020 (6+ years old) and is registered under CIN U11100MH2020PTC340370.
Cure Multitrade reported revenue of ₹14.47 Lakh for FY 2025 (down 34% YoY).
Cure Multitrade has 2 current directors:
- Sudhir Harishchanadra Wadkar - Additional Director
- Pritam Prafulchandra Karde - Director
Cure Multitrade reported a net profit of ₹8.26 Lakh (net margin 57.1%) and EBITDA of ₹10.94 Lakh (EBITDA margin 75.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Cure Multitrade is 57% over three years. In the latest year (FY 2025) revenue fell 34%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Cure Multitrade is U11100MH2020PTC340370. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cure Multitrade was incorporated on 06 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The registered office of Cure Multitrade is at Flat – 302 Shiv Sai Chsl Ltd Shiv Vallabh Road Near Saurashtra Marriage Hall Nr Patel, Borivali E, Mumbai, Maharashtra, India – 400066.
Cure Multitrade has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹40 Lakh.